Director, Cancer and Blood Disease Institute
Director, Pediatric Hematology-Oncology Fellowship Training Program
Attending Physician; Hematology, Oncology and Blood and Marrow Transplantation
Professor of Pediatrics (Clinical Scholar), Keck School of Medicine of USC
  • Summary
  • Publications
  • Research
  • Media
  • Locations

Alan S. Wayne, MD, serves as the Director of the Cancer and Blood Disease Institute at CHLA, the Head of the Division of Hematology, Oncology and Blood & Marrow Transplantation in the Department of Pediatrics, the Director of the Pediatric Hematology/Oncology Fellowship Training Program, the Associate Director for Pediatric Oncology at the USC Norris Comprehensive Cancer Center and Professor of Pediatrics at the Keck School of Medicine, University of Southern California. He oversees the research, clinical and education programs in pediatric hematology, oncology and hematopoietic stem cell transplantation within these institutions. Prior to joining CHLA/USC in 2013, Dr. Wayne served as clinical director of the Pediatric Oncology Branch of the National Cancer Institute at the National Institutes of Health for 14 years.

Clinical Interests

  • Hematologic malignancies: Hematopoietic stem cell transplantation
  • Bench-to-bedside development of targeted, immune-based and cellular therapies for leukemias and lymphomas, with a primary focus on relapsed/refractory acute lymphoblastic leukemia
  • Biology, prevention and treatment of relapse of hematologic malignancies after allogeneic hematopoietic stem cell transplantation
  • Natural history and treatment of rare lymphomas of childhood


Medical School: 

Honors Program in Medical Education, Northwestern University Medical School


Pediatrics, Department of Medicine, Boston Children’s Hospital, Harvard Medical School


Pediatrics, Department of Medicine, Boston Children’s Hospital, Harvard Medical School

Chief Residency, Pediatrics, Department of Medicine, Boston Children’s Hospital, Harvard Medical School


Pediatric Hematology-Oncology, Boston Children’s Hospital; Dana-Farber Cancer Institute



The American Board of Pediatrics, Sub-board of Pediatric Hematology-Oncology

Professional Memberships: 

American Pediatric Society
The American Society of Hematology
The American Society of Pediatric Hematology/Oncology
Children’s Oncology Group
Pediatric Blood and Marrow Transplant Consortium


The Best Doctors in America, 1995-2015
National Institutes of Health Director’s Award, NIH, 2007
The Sidney Farber Award, 1988

Other Information

Specialty Interest: 

Pediatric hematology-oncology

Research Interests: 

His primary research efforts are directed towards the development of new treatment approaches for leukemias and lymphomas with a focus on relapsed/refractory acute lymphoblastic leukemia. He develops and conducts collaborative laboratory, translational, and clinical investigations, including bench-to-bedside development of targeted, immune-based and cellular therapies, investigator-initiated clinical trials and industry-sponsored studies. He serves as the Medical Director of the Therapeutic Advances in Childhood Leukemia/Lymphoma (TACL) Consortium, which is a multinational clinical trials group that conducts Phase I and II trials. He also plays a leadership role in international efforts in the area of post-transplant relapse of hematologic malignancies, the primary aim of which is to study the biology, prevention and treatment of relapse after hematopoietic stem cell transplant. - Justin Turner Visits Children’s Hospital Los Angeles To Have Adidas Cleats Designed For Childhood Cancer Awareness Month

Billboard - TJ Martell Foundation Presents CHLA’s Alan Wayne With Spirit of Excellence Award

ABC7 - Athletes raise money for childhood cancer research at Children's Hospital Los Angeles in Malibu triathlon 

Hyundai Hope on Wheels – Hyundai Hope on Wheels Presents Children’s Hospital Los Angeles with Hyundai Hope Scholar and Young Investigator Grant Totaling $500,000 to Support Pediatric Cancer Research

Clinical trial to test immunotherapy for hard-to-treat leukemia

Yahoo Finance- Children’s Hospital Los Angeles to initiate Clinical Trial for Kids with Treatment-Resistant Leukemia

Science Daily- Unique next generation sequencing-based panel designed for pediatric cancer research

Hoy -  CHLA Joins forces with Councilmember Jose Huizar to Honor Childhood Cancer Awareness Month 

Fierce Biotech- Kite Pharma’s CART drug begins LA hospital trial in children 

Newsweek- New Therapy Leads to Lasting Remission in Leukemia Patients

ABC Good Morning America- Shutdown Prompts Fear, Confusion Among Cancer Patients

San Diego Tribune- CAR T cell leukemia therapy tested at Children's Hospital Los Angeles

CBS News- Childhood Cancer Deaths Continue to Decline

KTLA 5- Fighting Pediatric Cancer: The 30th Annual Nautica Malibu Triathlon

ABC 7 Eyewitness News- Elex Michaelson goes live with Dr. Wayne at Nautica Malibu Triathlon

FOX 11 — Courageous Teen Brings Awareness to Childhood Cancer One Lemonade Stand at a Time  

L.A. Times - Three-time Nautica Malibu Triathlon Celebrity Division Winner Talks about helping Kids at Children’s Hospital Los Angeles 

Science Daily — Disruptive technology for the treatment of hemophilia

KTLA — Children’s Hospital Los Angeles Preparing for Annual Triathlon in Malibu to Raise Funds for Childhood Cancer

ABC7 - Nautica Malibu Triathlon Raises $1.1 Million for CHLA

CBS News - Young Siblings Diagnosed With Same Brain Cancer Within Weeks of Each Other

Inside Edition – California Siblings With Same Type of Rare Brain Tumor Are Baffling Doctors 

ResearCHLA Magazine 2017

Cellular Therapy - Supercharging a patient’s own cells to battle blood diseases

ResearCHLA Blog

Tackling Leukemia with CAR T-Cells

“Patients don’t fail therapy. But sometimes, therapy fails them.”

Clinical Trial Results: Patients with Leukemia Show High Remission Rates after Immunotherapy

4650 Sunset Blvd.
MS #54
Los Angeles, CA 90027
Phone: 323-361-2121Office